AGENUS
Agenus develops and commercializes immunotherapies and vaccines for cancer and infectious diseases. The company's treatment aims to stimulate the immune system to recognize and fight cancer cells. Its goal is to treat cancers with novel combinations utilizing its unique portfolio of checkpoint antibodies, tumor microenvironment modifiers, vaccines, and adjuvants. In addition to a broad portfolio, the company has an accomplished team of scientists, novel technology platforms, and fully-integrated end-to-end capabilities from discovery to GMP manufacturing. It was established in 1994 and is headquartered in Lexington, Massachusetts.
AGENUS
Industry:
Biotechnology Medical Medical Device Therapeutics
Founded:
1994-01-01
Address:
Lexington, Massachusetts, United States
Country:
United States
Website Url:
http://www.agenusbio.com
Total Employee:
251+
Status:
Active
Contact:
(781)674-4400
Email Addresses:
[email protected]
Total Funding:
271.14 M USD
Technology used in webpage:
Domain Not Resolving IPv6 Gravity Forms AddThis Apple Whitelist Akamai Hosted
Similar Organizations
Romark Laboratories
Romark Laboratories discovers, develops and commercializes small molecules for treating infectious diseases and cancers.
Rapid Pathogen Screening
Rapid Pathogen Screening provides rapid point-of-care (POC) for identifying patients with infectious diseases.
Translate Bio
Translate Bio is a biotechnology company that specializes in biotechnology, RNA therapeutics, and rare diseases.
NeuroSigma
NeuroSigma develops and commercializes trigeminal nerve stimulation (TNS) for a variety of neurologic and psychiatric disorders.
NuCana BioMed
NuCana BioMed, a biopharmaceutical company, develops and commercializes rationally designed medicines for significant unmet medical needs.
Nicast
Nicast engages in the development and commercialization of medical devices made of electrospun polymer nano-fabrics.
NeurogesX
NeurogesX develops and commercializes therapies for chronic peripheral neuropathic pain.
Vedanta Biosciences
Vedanta Biosciences is a developer of immunotherapies designed to treat immune-mediated and infectious diseases.
Vaccinogen
Vaccinogen manufactures vaccines and other immunotherapeutic products for cancers and infectious diseases.
Vascular Perfusion Solutions
Vascular Perfusion Solutions develops medical devices designed to preserve and resuscitate vascularized organs.
Minerva Biotechnologies
Minerva Biotechnologies develops cancer immunotherapies and cancer drugs to target 80% of solid tumors and to prevent cancer metastasis.
Modular Medical
Modular Medical operates as a drug delivery tech developer.
Madrigal Pharmaceuticals
The Company is targeting treatment of both niche and prevalent indications, including fatty liver disease.
Medarex
Medarex, Inc. discovers, develops, and commercializes human antibody-based therapeutic products.
Mauna Kea Technologies
Mauna Kea Technologies specializes in designing, developing, and selling optical biopsy devices and tools.
Medtronic
Medtronic develops and manufactures medical device technologies and therapies to treat chronic diseases worldwide.
Mesa Biotech
Mesa Biotech offers DNA and RNA molecular testing services.
Longeviti
Longeviti develops and commercializes implantable neurosurgical devices.
Aleo BME
Developing and commercializing disruptive technologies in wound healing surgical glue and sealants
ARCA biopharma
ARCA biopharma develops genetically-targeted therapies for cardiovascular diseases.
Aethlon Medical
Aethlon Medical is a developer of immunotherapeutic technologies to combat infectious disease and cancer.
Aqua Medical
Aqua Medical provides Zreating Gastrointestinal Disease with Disruptive, Vapor-Based Endoscopic Ablation Therapy.
Abyrx
Abyrx develops, manufactures, and provides specialty biosurgical products for use during surgical procedures
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Expedeon
Expedeon is an expert in cutting-edge innovative reagents and services for life sciences and diagnostics.
EmboMedics
EmboMedics develops and commercializes resorbable and drug-loaded embolization devices for the treatment of multiple indications.
Evaxion Biotech
Evaxion Biotech is devoted to the discovery and development of vaccines against cancer and infectious diseases.
EnGeneIC
EnGeneIC develops and commercializes the treatment of cancer through the targeted delivery of therapeutic agents directly to cancer cells.
Elucid
Elucid enables precision medicine for cardiovascular disease by applying A.I to medical image analysis validated against true biology.
Eyevensys
Eyevensys creates ophthalmic therapeutic bio factories to sustainably treat major eye diseases.
Elastagen
Elastagen provides products that repair and augment skin by using elastin to maintain the skin’s elasticity and supple properties.
Bionomics
Bionomics discovers and develops therapeutics for cancer and diseases of the central nervous system.
Boston Therapeutics
Boston Therapeutics develops and commercializes novel compounds for unmet medical needs in the areas of diabetes and inflammatory diseases.
Trigemina
Trigemina develops non-opiate drug formulations and delivery systems for pain therapy.
Tarsa Therapeutics
Tarsa Therapeutics develops an oral formulation of calcitonin for the treatment and prevention of postmenopausal osteoporosis.
SPO
SPO develops and commercializes non-invasive pulse oximetry technologies to measure blood oxygen saturation and heart rate.
Slingshot Biosciences
Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.
Sutro Biopharma
Sutro Biopharma develops protein therapeutics by using OCFS protein synthesis technology.
Simedis
Simedis develops virtual reality simulators for medical education and training in all minimally invasive areas.
Second Genome
Second Genome offers a pipeline of microbiome modulators that impact infection, immunity and metabolic diseases.
SAGE Therapeutics
SAGE Therapeutics develops and delivers novel medicines for most debilitating and disabling central nervous system disorders.
SynerFuse
SynerFuse is a provider of traditional spine implants intended to offer long-term pain management without the use of addictive opioids
Simplify ASC
Simplify ASC develops a customizable, easy-to-use, and indispensable clinical and operational software.
Sanyou Medical
Sanyou Medical is a corporation that is therapy innovation oriented and devotes to the R&D.
Synta Pharmaceuticals
Synta Pharmaceuticals is focused on developing and commercializing small molecule drugs to treat cancer and chronic inflammatory diseases.
Dice Therapeutics
Dice Therapeutics develops a transformative platform designed for the discovery of novel small molecules.
Dash Medical Gloves
Dash Medical Gloves is a supplier of high quality, disposable Nitrile, Latex and Vinyl exam grade and non-medical gloves.
DAMAE Medical
DAMAE Medical develops an innovative imaging process for quick and non-invasive skin cancer detection.
HebeCell
HebeCell develops and commercializes cell-based therapeutics to treat incurable diseases.
Halozyme Therapeutics
Halozyme Therapeutics develops extracellular matrix targeting products for the insulin, cancer, dermatology and drug delivery markets.
Haemonetics
Haemonetics is a provider of blood and plasma supplies and services.
Humacyte
Humacyte develops products for vascular diseases and replacement of anatomical conduits.
iCAD
iCAD develops and delivers cancer detection and radiation therapy solutions, and services that enable clinicians to find and treat cancers.
Inscopix
Inscopix is pioneering a new paradigm in the quest to understand the brain and its diseases.
Iconic Therapeutics
Iconic Therapeutics develops and commercializes immunoconjugate proteins that trigger the immune system to destroy invader cells.
IMV Inc
IMV Inc applies its novel platform to the development of vaccines for cancer therapy, infectious diseases, and animal health.
IRX Therapeutics
IRX Therapeutics develops immune therapies designed to activate a patient’s immune system to defeat cancer and related diseases.
Imcyse
Developing disease specific immune therapies to treat severe, chronic auto-immune, inflammatory, allergic, infectious diseases and tumors.
GlobeImmune
GlobeImmune focused on developing products for the treatment of cancer and infectious diseases based on our proprietary Tarmogen® platform.
GVB Biopharma
GVB Biopharma specializes in hemp processing and cannabinoid-based consumer product manufacturing.
Generex Biotechnology
Generex Biotechnology develops and commercializes drug delivery systems and technologies for metabolic and immunological diseases.
Gamida Cell
Gamida Cell is an advanced cell therapy company committed to finding cures for patients with blood cancers and serious blood diseases.
Opsens
Opsens’ high accuracy fiber optic temperature sensor and ultra miniature pressure sensor offer many distinctive advantages for the Life
O2M Technologies
O2M Technologies develops oxygen imaging devices for effective cancer and regenerative medicine treatments.
OptiNose
OptiNose develops nasal drug delivery technologies and combined drug and device therapies.
Organovo Holdings
Organovo develops a range of tissue and disease models for medical research and therapeutic applications.
OncoArendi Therapeutics
OncoArendi Therapeutics specialized in developing and commercializing of therapeutics for neoplastic and inflammatory diseases.
Coherus Biosciences
Coherus Biosciences develops, manufactures, and commercializes biologic therapeutics for oncology and inflammatory diseases.
CEL-SCI
CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases.
Cantargia
Cantargia develops a therapy for the treatment of cancer by targeting a unique cell-surface receptor on malignant stem cells.
Celyad
Celyad is a provider of cell therapy treatments with an initial focus on cardiology and oncology.
CardiaLen
CardiaLen develops and commercializes pain-free cardioversion therapies for atrial fibrillation.
CytoImmune Therapeutics
CytoImmune Therapeutics develops novel, coordinated immunotherapy solutions for patients.
Celgene
Celgene discovers, develops and commercializes innovative therapies to treat cancer and immune-inflammatory-related diseases.
CeQur
CeQur develops and commercializes insulin delivery systems, giving people with type 2 diabetes freedom from multiple daily injections.
POLYNEURON
Polyneuron is a pharmaceutical company, committed to the development of a new drug class for the treatment of autoimmune disorders.
Pregenerate
We accelerate drug development and personalized medicine for arthritis using disease-on-a-chip model
PaxVax
PaxVax is a start-up developing candidate oral vaccines for key infectious diseases.
ProMIS Neurosciences
ProMIS Neurosciences develops therapeutic products and diagnostic devices targeting misfolded protein diseases.
Pulmatrix
Pulmatrix develops inhaled therapies for the treatment, prevention and transmission of infectious and progressive respiratory diseases.
Yorlabs
True to life: setting a new standard in intracardiac image guided therapy
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2015-12-27 | PhosImmune | PhosImmune acquired by Agenus | 44.9 M USD |
| 2015-04-08 | Celexion | Celexion acquired by Agenus | 4 M USD |
| 2014-01-13 | 4-Antibody AG | 4-Antibody AG acquired by Agenus | N/A |
Investors List
Incyte
Incyte investment in Post-IPO Equity - Agenus
Iroquois Capital
Iroquois Capital investment in Post-IPO Equity - Agenus
Hudson Capital Group
Hudson Capital Group investment in Post-IPO Equity - Agenus
Downsview Capital
Downsview Capital investment in Post-IPO Equity - Agenus
Official Site Inspections
http://www.agenusbio.com Semrush global rank: 1.39 M Semrush visits lastest month: 20.47 K
- Host name: 23.185.0.4
- IP address: 23.185.0.4
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Agenus" on Search Engine
Agenus - Wikipedia
Agenus Inc. is a Lexington, Massachusetts-based biotechnology company focused on immunotherapy including immuno-oncology, a field that uses the immune system to control or cure cancer. The company is developing checkpoint modulators (CPMs), patient-specific anti-cancer vaccines, and adjuvants desugned for use with various vaccines. CPM development is a particularly fast-moving field, since early products have produced unprecedented clinical benefit…See details»
Team | Agenus
Our Team. Leadership. Board of Directors. Advisory Board. Garo H. Armen, PhD. Chairman and Chief Executive Officer. Jennifer Buell, PhD. President and CEO of MiNK …See details»
Our History | Agenus
Agenus discovers, manufactures and develops immuno-oncology products. The company’s I-O portfolio is comprised of checkpoint antibodies, cell therapies, vaccines, and …See details»
Agenus - Crunchbase Company Profile & Funding
Agenus develops and commercializes immunotherapies and vaccines for cancer and infectious diseases. The company's treatment aims to stimulate the immune system to …See details»
Agenus Announces Updated Phase 1 Data and Progress …
April 12, 2024. Download. Updated Phase 1 data demonstrate a 12-month overall survival (OS) of 71% and 18-month OS of 62% Company plans to discuss encouraging Phase 2 …See details»
Agenus | LinkedIn
Agenus is a leading immuno-oncology company targeting cancer and infectious diseases with a comprehensive pipeline of immunological agents.See details»
Curing cancers with innovation and speed - Nature
Agenus is an immuno-oncology company with an extensive portfolio and technology platforms to drive speedy innovation and development. The company and its partners …See details»
Agenus Initiates Botensilimab Phase 2 ACTIVATE Trials …
LEXINGTON, Mass., Sept. 12, 2022 (GLOBE NEWSWIRE) -- Agenus (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of therapeutics designed to …See details»
Agenus Inc. - Agenus Announces Preclinical Data on …
Mar 6, 2024 Agenus Announces Preclinical Data on BMS-986442 (AGEN1777) at AACR 2024. March 6, 2024. Download. Preclinical findings demonstrate superior …See details»
New Agenus Subsidiary, SaponiQx, Builds Innovative Adjuvant
Sep 10, 2021 Agenus is a clinical-stage immuno-oncology company focused on the discovery and development of therapies that engage the body's immune system to fight …See details»
Agenus: 2024 May Finally Be The Year For A Major Turnaround
Jan 18, 2024 Agenus is a beaten-down immuno-oncology biotech stock that has not participated in the recent biotech rally despite a promising pipeline and multiple …See details»
Agenus Prioritizes Resources to Accelerate Registration and ...
Aug 23, 2023 LEXINGTON, Mass.-- (BUSINESS WIRE)-- Agenus Inc. (“Agenus”) (Nasdaq: AGEN), a pioneer in immuno-oncology, today announced a strategic initiative …See details»
Agenus Announces Preclinical Data on BMS-986442 …
LEXINGTON, Mass., March 06, 2024--Agenus Inc. ("Agenus") (Nasdaq: AGEN), a leader in discovering and developing novel immunological agents to treat various cancers, …See details»
Member Spotlight: Q&A with Agenus - MassBio
Dec 01, 2023. Every month, MassBio spotlights a member company and its efforts in advancing the life sciences industry and supporting the patients we serve. In December …See details»
Agenus Reports Fourth Quarter and Full Year 2023 Results
Mar 14, 2024 LEXINGTON, Mass.-- (BUSINESS WIRE)-- Agenus Inc. (“Agenus”) (Nasdaq: AGEN), a leader in discovering and developing novel immunological agents to …See details»
Agenus to Provide First Quarter 2024 Financial Report and …
6 days ago LEXINGTON, Mass., April 23, 2024 -- ( BUSINESS WIRE )--Agenus Inc. ("Agenus") (Nasdaq: AGEN), a leader in developing novel immunological agents to treat …See details»
Agenus Prioritizes Resources to Accelerate Registration and ...
Aug 23, 2023 LEXINGTON, Mass.-- ( BUSINESS WIRE )--Agenus Inc. (“Agenus”) (Nasdaq: AGEN), a pioneer in immuno-oncology, today announced a strategic initiative …See details»
Up 40%: Is This Red-Hot Growth Stock Still a Buy?
1 day ago Key Points. Agenus, a small-cap immunotherapy company, notched a 40% gain last Friday. Investors appear to be bidding up the stock ahead of first-quarter earnings on …See details»
Agenus Inc. - Agenus to Provide Corporate Update and Fourth …
Feb 29, 2024 LEXINGTON, Mass.-- (BUSINESS WIRE)-- Agenus Inc. (“Agenus”) (Nasdaq: AGEN), a leader in discovering and developing novel immunological agents to …See details»
Agenus | Devex
AGENUS IS DESIGNED TO DELIVER INNOVATION WITH SPEED FOR PATIENTS WITH CANCER. Read more. Type of organization. Independent/None. United States. 1 office. …See details»